Authors:
Zhu, J
Lallemand-Breitenbach, V
de The, H
Citation: J. Zhu et al., Pathways of retinoic acid- or arsenic trioxide-induced PML/RAR alpha catabolism, role of oncogene degradation in disease remission, ONCOGENE, 20(49), 2001, pp. 7257-7265
Authors:
Lallemand-Breitenbach, V
Zhu, J
de The, H
Citation: V. Lallemand-breitenbach et al., Promyelocytic leukemia, a unique model to design treatments targeting oncogenes, M S-MED SCI, 17(1), 2001, pp. 14-22
Authors:
Regad, T
Saib, A
Lallemand-Breitenbach, V
Pandolfi, PP
de The, H
Chelbi-Alix, MK
Citation: T. Regad et al., PML mediates the interferon-induced antiviral state against a complex retrovirus via its association with the viral transactivator, EMBO J, 20(13), 2001, pp. 3495-3505
Authors:
Lallemand-Breitenbach, V
Zhu, J
Puvion, F
Koken, M
Honore, N
Doubeikovsky, A
Duprez, E
Pandolfi, PP
Puvion, E
Freemont, P
de The, H
Citation: V. Lallemand-breitenbach et al., Role of promyelocytic leukemia (PML) sumolation in nuclear body formation,11S proteasome recruitment, and As2O3-induced PML or PML/retinoic acid receptor alpha degradation, J EXP MED, 193(12), 2001, pp. 1361-1371
Authors:
Lallemand-Breitenbach, V
Guillemin, MC
Janin, A
Daniel, MT
Degos, L
Kogan, SC
Bishop, JM
de The, H
Citation: V. Lallemand-breitenbach et al., Retinoic acid and arsenic synergize to eradicate leukemic cells in a mousemodel of acute promyelocytic leukemia, J EXP MED, 189(7), 1999, pp. 1043-1052
Authors:
Duprez, E
Saurin, AJ
Desterro, JM
Lallemand-Breitenbach, V
Howe, K
Boddy, MN
Solomon, E
de The, H
Hay, RT
Freemont, PS
Citation: E. Duprez et al., SUMO-1 modification of the acute promyelocytic leukaemia protein PML: implications for nuclear localisation, J CELL SCI, 112(3), 1999, pp. 381-393